ASSENTFARMA
The computed 12-month bankruptcy probability of ASSENTFARMA is 0.4% (very low). The 2024 annual accounts show equity of €831k and a net result of €137k. Equity is growing by ~8.5% per year across the filed fiscal years. Its solvency ranks better than 92% of 1215 sector peers (fiscal year 2024). The company has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €831k |
| Net result | €137k |
| Staff (FTE) | 0.3 |
| Better than sector | 92% |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 76.9% | 20.4% | |
| Net result | €137k | €26k | |
| Equity | €831k | €142k | |
| Gross operating margin | €197k | €217k | |
| Staff costs | €14k | €164k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €182k |
| Net profit | €137k |
| Cash flow | €150k |
| Staff costs | €14k |
| Income taxes | €28k |
| Dividends | - |
| Total assets | €1.08M |
| Equity | €831k |
| Debt | €250k |
| of which ≤ 1y | €243k |
| of which > 1y | - |
| Working capital | €790k |
| Employees (FTE) | 0.3 |
| 2024 | |
|---|---|
| Current ratio | 4.26 |
| Quick ratio | 3.70 |
| Working capital ratio | 73.0% |
| Solvency | 76.9% |
| Debt / equity | 0.30 |
| Long-term debt ratio | - |
| Interest coverage | 17.06 |
| Gross margin | - |
| Net margin | - |
| ROA | 12.7% |
| ROE | 16.5% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.08M |
| Fixed assets | 21/28 | €50k |
| Tangible fixed assets | 22/27 | €50k |
| Current assets | 29/58 | €1.03M |
| Stocks & contracts in progress | 3 | €135k |
| Amounts receivable within one year | 40/41 | €277k |
| Investments | 50/53 | €250k |
| Cash & bank | 54/58 | €358k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.08M |
| Equity | 10/15 | €831k |
| Contributions / capital | 10/11 | €62k |
| Reserves | 13 | €146k |
| Accumulated profits (losses) | 14 | €624k |
| Amounts payable | 17/49 | €250k |
| Amounts payable within one year | 42/48 | €243k |
| Trade debts payable within one year | 44 | €77k |
| Income statement | ||
| Gross operating margin | 9900 | €197k |
| Operating result | 9901 | €169k |
| Financial income | 75 | €4k |
| Financial charges | 65 | €11k |
| Result before taxes | 9903 | €164k |
| Income taxes | 67/77 | €28k |
| Net result for the period | 9904 | €137k |
| Result to be appropriated | 9905 | €137k |
-
Current07-12-2023 → present
-
CLAVANTILegal entityDirector· perm. rep.: CLAESEN Gustaaf Gerard EmileState Gazette act 24320384 (11-01-2024)Current07-12-2023 → present
2 events
- 07-12-2023 Mandate renewed· Director
- 07-12-2023 Appointed· Managing director
-
Current21-11-2017 → present
2 events
- 07-12-2023 Mandate renewed· Director
- 21-11-2017 Mandate renewed· Director
Historic, not recently confirmed (1)
-
Clavanti BVBALegal entityDirector· perm. rep.: Gustaaf ClaesenState Gazette act 17162272 (21-11-2017)Not recently confirmedlast confirmed in an act from 2017
2 events
- 21-11-2017 Mandate renewed· Director
- 31-10-2017 Appointed· Managing director
| NACE primary | Retail trade(47730) |
| Legal form | Public limited company(014) |
| Incorporation | 04-01-2002 |
| Status | Active |
| Postal code | 3460 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24002F0225/00C002 | Flanders | 1,643 m² | 1 · 298 m² | 9.8 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
05-05-2026 Officer resignation · General meeting · Act object
- Filing: 2026-04-13 · Assentfarma
- Publication: 2026-05-05 · Assentfarma
- Officer resignation: date: 2025-04-30, role: bestuurder · Vandoninck Romain
- General meeting: date: 2025-04-29, type: Buitengewone Algemene vergadering · Assentfarma
- Act object: Ontslag bestuurder
Technical details
{
"facts": [
{
"type": "filing",
"quote": "13 APR. 2026",
"value": "2026-04-13",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "05/05/2026",
"value": "2026-05-05",
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "heeft beslist om onderstaande persoon te ontslagen als bestuurder vanaf 30 april 2025",
"value": {
"date": "2025-04-30",
"role": "bestuurder"
},
"object": "e1",
"subject": "e2"
},
{
"type": "general_meeting",
"quote": "De Buitengewone Algemene vergadering der Aandeelhouders dd 29/04/2025",
"value": {
"date": "2025-04-29",
"type": "Buitengewone Algemene vergadering"
},
"object": null,
"subject": "e1"
},
{
"type": "act_object",
"quote": "Onderwerp akte: Ontslag bestuurder",
"value": "Ontslag bestuurder",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 1000,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0476.449.350",
"kind": "company",
"name": "Assentfarma",
"attrs": {
"seat": "Dorpsstraat 8, 3460 Bekkevoort",
"legal_form": "Naamloze vennootschap"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Vandoninck Romain",
"attrs": {
"address": "Heggebossenweg 19, 3980 Tessenderlo"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Staf Claesen",
"attrs": {
"role": "vast vertegenwoordiger Clavanti BV",
"role_company": "Clavanti BV"
}
}
]
}11-01-2024 1 director appointed, 2 reappointed
- CLAESEN Gustaaf Gerard Emile, Gedelegeerd bestuurder
- CLAESEN Gustaaf Gerard Emile, Bestuurder
- VANDONINCK Romain, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "CLAESEN Gustaaf Gerard Emile",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0472642594",
"name": "CLAVANTI",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-12-07",
"evidence_quote": "De vergadering beslist met eenparigheid van stemmen om met ingang van heden te herbenoemen als bestuurders voor een periode van zes jaar: 1- De besloten vennootschap \u201CCLAVANTI"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "VANDONINCK Romain",
"address": null,
"birth_date": null
},
"effective_date": "2023-12-07",
"evidence_quote": "De vergadering beslist met eenparigheid van stemmen om met ingang van heden te herbenoemen als bestuurders voor een periode van zes jaar: ... 2- De heer VANDONINCK Romain"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "CLAESEN Gustaaf Gerard Emile",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0472642594",
"name": "CLAVANTI",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-12-07",
"evidence_quote": "De comparanten in hun hoedanigheid van leden van de raad van bestuur verklaren met eenparigheid van stemmen te benoemen: - tot afgevaardigde bestuurder: De besloten vennootschap \u201CCLAVANTI"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0476.449.350",
"name_full": "ASSENTFARMA",
"legal_form": "NV"
}
}21-11-2017 1 director appointed, 2 reappointed
- Gustaaf Claesen, Gedelegeerd bestuurder
- Vandoninck Romain, Bestuurder
- Gustaaf Claesen, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Vandoninck Romain",
"address": null,
"birth_date": null
},
"evidence_quote": "Op de buitengewone algemene vergadering van dinsdag 31 oktober 2017 werd beslist om volgende personenen te herbenoemen ais bestuurder: - De Heer Vandoninck Romain, geboren te Geel 19 November 1951, NN 51.11.19-103.87"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gustaaf Claesen",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Clavanti BVBA",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Op de buitengewone algemene vergadering van dinsdag 31 oktober 2017 werd beslist om volgende personenen te herbenoemen ais bestuurder: - Clavanti BVBA met zetel te 3460 Bekkevoort, Dorpsstraat 8, vertegenwoordigd door vast vertegenwoordiger Mr Gustaaf Claesen, wonende te 3460 Bekkevoort, Dorpsstraat"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Gustaaf Claesen",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Clavanti BVBA",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2017-10-31",
"evidence_quote": "Tevens wordt beslist om onderstaande te benoemen als afgevaardigd bestuurder: Clavanti BVBA met zetel te 3460 Bekkevoort, Dorpsstraat 8, vertegenwoordigd door haar vast vertegenwoordiger, Mr Claesen Gustaaf, wonende te 3460 Bekkevoort, Dorpsstraat 8 Deze benoeming geidt voor een periode van 6 jaar v"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0476.449.350",
"name_full": "ASSENTFARMA",
"legal_form": "NV"
}
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | ASSENTFARMA |